English

Ubrogepant

Ubrogepant Featured Image
  • Ubrogepant

Short Description:

API’s Name CAS No. US DMF Patent Expiry Date (US) Current Status 
Ubrogepant 1374248-77-7 Dec, 2027   Sep.28, 2035 estimated PV Completion – Oct, 2027

 

[Indication] 

For the acute treatment of migraine with or without aura in adults.


Product Detail

Product Tags

  • Previous:
  • Next:
    • Write your message here and send it to us

    Products categories